Baudax Bio (BXRXQ) Income Statement
Baudax Bio Income Statement
Last quarter (Q3 2023), Baudax Bio's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q3, Baudax Bio's net income was $-1.93M. See Baudax Bio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| $ 1.27M | $ 1.08M | $ 493.00K | $ 0.00 | $ 0.00 | |
| $ -5.74M | $ -1.36M | $ -1.24M | $ 0.00 | $ 0.00 | |
| $ 51.07M | $ 17.64M | $ 73.55M | $ 32.52M | $ 73.53M | |
| Depreciation and Amortization | $ 2.16M | $ 2.82M | $ 2.55M | $ 480.00K | $ 396.00K |
| $ -33.58M | $ -49.56M | $ -72.19M | $ -32.08M | $ -64.64M | |
| $ -56.81M | $ -19.01M | $ -74.79M | $ -32.52M | $ -73.53M | |
| $ -1.98M | $ -763.00K | $ -1.31M | $ -38.00K | $ -132.00K | |
| $ -58.80M | $ -19.77M | $ -76.10M | $ -32.56M | $ -73.67M | |
| $ -58.80M | $ -19.77M | $ -76.10M | $ -32.56M | $ -73.67M | |
| Per Share Metrics | |||||
| Basic EPS | $ -177.30 | $ -361.16 | $ -5714.80 | $ -4872.07 | $ -11361.35 |
| Diluted EPS | $ -177.30 | $ -361.16 | $ -5714.80 | $ -4872.07 | $ -11361.35 |
| Weighted Average Shares Outstanding | 331.62K | 54.74K | 13.31K | 6.68K | 6.48K |
| Weighted Average Shares Outstanding (Diluted) | 331.62K | 54.74K | 13.31K | 6.68K | 6.48K |
Currency in USD